Date: 2013-03-22
Type of information: Collaboration agreement
Compound: predictive in silico or computer simulated skin model
Company: Bio-Modeling Systems (France) Persistent Systems (USA)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: Bio-Modeling Systems, a French integrative systems biology company and, Persistent Systems, a global leader in software product and technology services, have announced a joint systems biology research and development initiative. The strategic initiative is the world’s first collaborative effort that marries non-mathematical heuristic modeling with mathematical modeling designed to increase the success rates of drug discovery and formulation development by pharmaceutical and cosmetic industries.
A key deliverable of this joint initiative is the development of a predictive in silico or computer simulated skin model that will help eliminate the need to use animals in contact allergy testing. This announcement follows on the heels of the European Union’s ban on the import and sale of cosmetics containing ingredients tested on animals, offering the industry a highly effective and essential alternative.
Bio-Modeling Systems’ team of highly skilled biologists will combine the outputs of its CADI*™ proprietary heuristic modeling platform with a powerful new software platform, Cell-in-Silico, developed by Persistent, resulting in the first heuristic model of skin cell interplay mechanisms to be enhanced through mathematical modelling.
Financial terms:
Latest news:
